# A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next dose, the nurse reviews recent lab values. Which finding most concerns the nurse and warrants holding the dose plus notifying the provider?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en  
> language: en  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## Question

A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next dose, the nurse reviews recent lab values. Which finding most concerns the nurse and warrants holding the dose plus notifying the provider?

## Option

1. BUN level is 18 mg/dL, which is unchanged from the baseline prior to vancomycin therapy
2. Trough vancomycin level 24 mcg/mL with serum creatinine increased from 0.8 to 1.6 mg/dL **✔ Correct answer**
3. The client reports a single episode of mild nausea following the most recent vancomycin infusion
4. Trough vancomycin level is 15 mcg/mL and serum creatinine remains stable at 0.9 mg/dL

**Correct answer: 2**

## Explanation

Vancomycin nephrotoxicity is dose- and trough-dependent. A trough above 20 mcg/mL combined with a doubling of serum creatinine meets KDIGO criteria for acute kidney injury. The nurse must hold the dose and notify the provider for level review or dose modification. Trough 12 mcg/mL is sub-therapeutic but not nephrotoxic. BUN 18 mg/dL is within normal limits. Mild nausea is a common GI side effect that does not require holding.

## In-depth explanation

Clinical Judgment
Vancomycin requires therapeutic drug monitoring to balance efficacy and renal safety. Therapeutic trough for serious MRSA: 15-20 mcg/mL. Toxicity threshold: trough >20 mcg/mL with creatinine rise. Doubling of creatinine from baseline meets KDIGO Stage 1 AKI.

Memory Tip
Vanco trough >20 + creatinine doubled = HOLD and notify

KR vs US
US uses AUC/MIC monitoring (target 400-600) when available; trough 15-20 mcg/mL acceptable surrogate. Korean tertiary centers also adopt AUC monitoring; community hospitals still rely on trough.

## Clinical scenario

Clinical Practice Guide
2020 IDSA / ASHP / SIDP / PIDS guidelines recommend AUC/MIC monitoring of vancomycin (target AUC 400-600 mg·h/L) for serious MRSA infection. Trough 15-20 mcg/mL remains an acceptable surrogate. Hold or adjust dose when trough exceeds 20 mcg/mL or creatinine rises >0.5 mg/dL above baseline.

Caution
Concurrent nephrotoxic drugs (aminoglycosides, NSAIDs, contrast dye, piperacillin-tazobactam) compound vancomycin renal injury. Always recheck creatinine every 48-72 hours during therapy.

## Key concepts

- **Vancomycin trough** — Serum vancomycin level drawn 30 minutes before the next scheduled dose. Therapeutic for serious MRSA: 15-20 mcg/mL. Above 20 mcg/mL: toxicity risk; recheck creatinine and consider dose adjustment.
- **Acute kidney injury (KDIGO)** — KDIGO Stage 1 AKI: serum creatinine increase of 0.3 mg/dL within 48 hours OR 1.5 to 1.9 times baseline within 7 days, OR urine output
- **Therapeutic drug monitoring (TDM)** — Lab-guided dosing for narrow-therapeutic-index drugs. Required for vancomycin, aminoglycosides, lithium, digoxin, phenytoin, theophylline. Trough drawn 30 minutes pre-dose; peak drawn after distribution phase.

## Related questions

- [A nurse is reviewing the morning lab results for an adult client receiving warfarin for at…](https://mymerci.kr/pages/nclex_q.php?qn_id=360515&lang=en)
- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en)
- [An 80-year-old male with heart failure is prescribed digoxin 0.125 mg daily. During mornin…](https://mymerci.kr/pages/nclex_q.php?qn_id=372686&lang=en)
- [A 38-year-old female with rheumatoid arthritis is being discharged with a new prescription…](https://mymerci.kr/pages/nclex_q.php?qn_id=372687&lang=en)
- [A 62-year-old patient is being discharged after a deep vein thrombosis and will continue e…](https://mymerci.kr/pages/nclex_q.php?qn_id=372707&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._

